BioSpace News Archive

Konica Minolta Healthcare Americas, Inc., announced the introduction of PocketPro H2, a new wireless handheld ultrasound device for general imaging in point-of-care applications.

Bridge to Life Ltd., a leading global supplier of organ preservation and perfusion technologies, announced results from interim analysis of its multicenter, randomized, controlled liver clinical trial presented at the 2023 American Transplant Congress.

Direct Biologics Announces Publication of Significant Survival Benefit with ExoFlo ™ in its Phase 2 Randomized Controlled Clinical Trial in the Journal CHEST.

Spectacular Labs Inc., an innovator of next-generation rapid pathogen testing, announced that it will be showcasing its groundbreaking technology for the first time at the upcoming International Association for Food Protection 2023 Annual Meeting.

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced it will highlight core products from its joint preservation and restoration portfolio at the 2023 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting on July 13-16th in Washington, D.C.

Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced the appointment of Giorgia Scapin, Ph.D., as Chief Scientific Officer.

Dr. Reddy’s Laboratories Ltd. announced that its Biologics License Application (BLA) for its proposed biosimilar rituximab candidate DRL_RI has been accepted for a substantive review by the U.S. Food and Drug Administration (USFDA).

Wavely Diagnostics, Inc. raised $1.35MM in new funding to advance its first-of-its-kind digital diagnostics platform for enabling virtual ear infection care for children, bringing Wavely’s total investor and grant funding to $6.35MM.

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt Germany, announced the expansion of its facility in Lenexa, Kansas, adding 98,000 square feet of lab space and production capability to manufacture cell culture media.

DENTSPLY SIRONA Inc. announced that the Company will be hosting an investor conference call and live webcast on Thursday, August 3, 2023, at 8:30 am ET to review its second quarter financial results.